Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, Genoway, NCI, TransTech Pharma, Genedata

Premium

Invitrogen and Genoway to Co-Market RNAi Services

Invitrogen and Genoway will co-market RNAi-related services, the companies said last week.

Under the agreement, Invitrogen will combine its expertise in RNAi research technologies with Genoway's portfolio of transgenesis technologies and RNAi in vivo experience to create a new services platform. The platform will allow RNAi vector design through the creation of RNAi transgenic rodent models.

Both companies will share revenues, Genoway said.

Additional details were not disclosed.


NCI RFA Offers $3M for Developing Molecular Technologies

The National Cancer Institute last week allocated nearly $3 million for research on developing cancer-relevant molecular technologies, according to a request for applications published on the National Institutes of Health web site.

NCI said it expects to award between 10 and 15 new and/or competing continuation grants for periods up to two or three years, depending on the award mechanism.

The institute will consider proposals that involve methods and tools to enable research, including instrumentation, techniques, and devices. Molecular technologies are distinct from resources such as databases, individual reagents, therapeutic agents, and tissue repositories, which are not included under this initiative.

The receipt dates for intents are Jan. 23 and April 26. The applications must be received by Feb. 22 and May 26.


TransTech Pharma Selects Genedata's High Throughput Screener

TransTech Pharma signed a multi-year license for Genedata's high throughput screening-analysis software, Genedata said last week.

TransTech Pharma scientists will use the software, Genedata Screener, to enhance their efforts to develop small molecules as therapeutics for treating human diseases.

Screener has been integrated with TransTech Pharma's IT and screening infrastructure to automate data quality evaluation and standardize the analysis of compound bioactivity, Genedata said.

Financial details were not disclosed.

 

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.